Autoimmune Biotech Zenas Gets $118M to Take Antibody Drug Into Phase 3

Zenas BioPharma’s Series B financing was the biggest one of the week. Other startups that emerged with new cash include Juvena Therapeutics, Sensorium Therapeutics, and NRG Therapeutics.